4.5 Letter

Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients

Heinz-Peter Schultheiss et al.

Summary: The study demonstrated that suppression of B19V transcriptional activity by the nucleoside analogue telbivudine (LTD) improved clinical outcomes significantly, especially in terms of cardiac function and quality of life for patients.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies

Felicitas Escher et al.

ESC HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts

Carsten Tschoepe et al.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2019)

Article Cardiac & Cardiovascular Systems

Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity

Sophie Van Linthout et al.

ESC HEART FAILURE (2018)

Article Cardiac & Cardiovascular Systems

Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy

Heinz-Peter Schultheiss et al.

CLINICAL RESEARCH IN CARDIOLOGY (2016)